Andere Sprachen MiMedx Group, Inc.

Aktien

A0MS6X

US6024961012

MDXG

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 01.05.2024			% 5 Tage	% 1. Jan.
7,31 ^USD	+18,67 %		+13,69 %	-16,65 %

30.04.	Transcript : MiMedx Group, Inc., Q1 2024 Earnings Call, Apr 30, 2024
27.03.	MiMedx Group: FDA bestätigt, dass Axiofill die regulatorischen Standards für gewebebasierte Produkte nicht erfüllt	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 Revenue $84.7M, vs. Street Est of $79.4M	30.04.
Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 EPS $0.07, vs. Street Est of $0.04	30.04.
MiMedx: Q1 Earnings Snapshot	30.04.
MiMedx Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30.04.
MIMEDX Announces First Quarter 2024 Operating and Financial Results	30.04.
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30	16.04.
MIMEDX Provides Update on AXIOFILL Request for Designation from FDA	28.03.
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024	27.03.
MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products	27.03.
MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit	27.03.
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA	27.03.
MiMedx Group, Inc. Provides Update on AXIOFILL Request for Designation from FDA	27.03.
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	20.03.
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	20.03.
MiMedx Launches E-Commerce Platform	13.03.
MIMEDX Introduces E-Commerce and Account Management Platform	13.03.
Mimedx Introduces E-Commerce and Account Management Platform	13.03.
MIMEDX Announces Appointment of Two New Independent Directors	04.03.
MiMedx Group, Inc. Announces Appointment of New Independent Directors	04.03.
Spectral AI Names Peter Carlson Chief Executive Officer; Reaffirms 2024 Preliminary Revenue Guidance	01.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen MiMedx Group, Inc.

Aktien

A0MS6X

US6024961012

MDXG

Andere Sprachen

Filter